What Happens to Babies When Pregnant Women Take Semaglutide? New Research Has Answers

A comprehensive review of over 1,100 pregnancies exposed to semaglutide found no consistent connection to major birth defects, but researchers identified some complications that warrant further investigation. This is the first systematic review examining how the popular weight loss drug affects developing babies and newborns, offering clarity on a question many women taking medications like Ozempic and Wegovy are asking their doctors.

What Does the Research Actually Show About Semaglutide in Pregnancy?

Researchers analyzed five studies covering 1,128 pregnancies where women were exposed to semaglutide during pregnancy. The headline finding is reassuring: there was no consistent link between semaglutide use and major congenital malformations—meaning birth defects were not elevated compared to what doctors would expect in the general population. This matters because when a medication becomes widely used, especially for weight management, pregnant women and their doctors need to know whether it poses risks to fetal development.

However, the review did identify three complications that appeared in the data, though researchers emphasized that more research is needed to establish whether semaglutide actually caused them. These included preterm birth (babies born before 37 weeks of pregnancy), macrosomia (babies born significantly larger than average), and neonatal hypoglycemia (dangerously low blood sugar in newborns immediately after birth). The fact that these outcomes were observed doesn't automatically mean the medication caused them—other factors like the mother's underlying health conditions could play a role.

Why Is This Research Important for Women Considering Pregnancy?

Semaglutide belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) agonists, which work by mimicking a natural hormone that helps regulate blood sugar and appetite. These medications have become increasingly popular not just for weight loss, but also for managing type 2 diabetes and, in some cases, helping women with polycystic ovary syndrome (PCOS) improve their fertility. As more women of childbearing age use these drugs, understanding their safety in pregnancy has become a critical clinical question.

The challenge is that pregnancy is one of the most tightly regulated periods for medication use. Doctors are understandably cautious about recommending any drug during pregnancy unless the benefits clearly outweigh potential risks. The absence of a proven link to birth defects is meaningful, but the appearance of other complications—even without confirmed causation—means women and their healthcare providers need honest conversations about what we know and don't know.

What Should Women Know Before Getting Pregnant?

The research team emphasized that further large-scale studies are needed to clarify the safety of semaglutide in pregnancy. This is standard language in medical research, but it reflects an important reality: five studies covering just over 1,100 pregnancies, while valuable, represent a relatively small sample size compared to the millions of women now using GLP-1 drugs globally. Larger, more detailed studies could help researchers understand whether the complications observed were coincidental or truly linked to the medication.

For women currently taking semaglutide or considering it, this doesn't mean the drug is unsafe in pregnancy—the data on birth defects is reassuring. But it does mean that pregnancy planning should involve a detailed conversation with your doctor about your individual health situation, the reasons you're taking the medication, and whether continuing, pausing, or switching to an alternative approach makes sense for your specific circumstances.

Steps to Take If You're on Semaglutide and Planning Pregnancy

• Schedule a preconception visit: Talk with your obstetrician or primary care doctor before trying to conceive. Bring a list of all medications you're taking, including semaglutide, and discuss your health goals and any underlying conditions like diabetes or PCOS.
• Review your medication timeline: Ask your doctor whether semaglutide should be continued, paused, or replaced during pregnancy planning and pregnancy itself. The decision depends on why you're taking it and your individual health needs.
• Understand the monitoring plan: If you do become pregnant while on semaglutide or decide to continue it, ask what additional monitoring your baby will receive, including screening for low blood sugar after birth and assessment of birth size.
• Get clarity on what's unknown: Ask your doctor to explain what the current research does and doesn't tell us. Understanding the limits of the evidence helps you make informed decisions rather than relying on fear or assumptions.

The Bottom Line: What Experts Want You to Know

The absence of a proven link between semaglutide and major birth defects is genuinely good news for women who need this medication for their health. At the same time, the observation of preterm birth, larger-than-average babies, and newborn low blood sugar suggests that pregnancy while on semaglutide requires careful medical oversight. This isn't unusual—many medications used safely in non-pregnant adults require special consideration during pregnancy.

The key takeaway is that semaglutide in pregnancy is not a settled question with a simple yes-or-no answer. Instead, it's a clinical decision that should be made collaboratively between you and your healthcare team, based on your specific health situation, the reasons you're taking the medication, and your pregnancy plans. As more data accumulates, our understanding will likely become clearer, but for now, informed decision-making with your doctor is the safest approach.